select trial semaglutide ppt was published today in NEJM. Below, I summarize the trial and the drug in this thread.... - Dr Shailesh Singh Clinical Trials Overview Semaglutide Molecule

Without intentional resistance training and adequate protein, weight loss includes 2040% lean muscle mass

After May 22, 2025, 503B facilities will also cease, further limiting options unless the court intervenes

Always double-check the date before injecting

So, disregarding the impact on hunger, is it working

In others particularly at higher doses or during dose escalation the net effect may be altered intestinal motility and transit patterns that result in looser stools or diarrhoea

PAXLOVID- nirmatrelvir and ritonavir Pfizer Laboratories Div Pfizer Inc ---------- PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death